ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
CHK1/2激酶抑制剂ACR-368治疗复发或难治性促纤维增生性小圆细胞肿瘤患者的I/II期临床试验结果
期刊:
影响因子:
doi:10.1200/OA-24-00095
Slotkin, Emily K; Mauguen, Audrey; Dela Cruz, Filemon S; Ortiz, Michael V; Avutu, Viswatej; Meyers, Paul A; Wexler, Leonard H; O'Donohue, Tara J; Kinnaman, Michael D; Kelly, Ciara M; D'Angelo, Sandra P; Keohan, Mary Lou; Gounder, Mrinal M; Thornton, Katherine; Nacev, Benjamin A; Chi, Ping; Rosenbaum, Evan; Dickson, Mark; Pachhal, Sagarika; Somwar, Romel; Ladanyi, Marc; Robb, Caroline; Pandit-Taskar, Neeta; Hwang, Sinchun; Price, Anita; Behr, Gerald; Reed, Damon R; Kentsis, Alex; Kung, Andrew L; Bender, Julia Glade; Tap, William D